EconomyGrifols leverages its biopharmaceuticals division to raise profit to €227M in the first halfAlbert Cadanet Vilà28-07-2026
EconomyGrifols reorganizes its biopharma business and separates the US from the rest of the worldAlberto Prieto01-07-2026
EconomyGrifols justifies the stock market listing in the US with the argument that the market "recognizes its value"Alberto Prieto18-06-2026
![The headquarters of Grifols](data:image/svg+xml,%3Csvg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 16 9"%3E%3C/svg%3E)